| Product Name: | Pentoxifylline Extended-Release Tablets |
| Brand Name: | Generics |
| Strength: | 400mg |
| Dosage Form: | Tablets (Film-coated) |
| Route of Administration: | Via oral Route |
| Packing: | 90s, 100s, 500s, 1000s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Antihemorrhagic Drugs, antiplatelet |
| Indication: | Pentoxifylline is indicated in the treatment of peripheral vascular disease, including intermittent claudication and rest pain. |
| Storage: | Protect from moisture at a temperature not exceeding 25˚C. Do not freeze. Keep the container tightly closed in order to protect it from moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
Pentoxifylline Extended-Release Tablets USP 400mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Pentoxifylline Extended-Release Tablets USP 400mg
Each extended-release film-coated tablet contains:
Pentoxifylline USP……………………400mg
Excipients…………………………………. q.s.
Colours: Erythrosine
THERAPEUTIC INDICATIONS:
Pentoxifylline can be used to treat:
a) Peripheral vascular disease (poor circulation to the arms and legs).
b) Intermittent claudication (pain on walking or at rest caused by poor circulation to the legs).
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Storage: Protect form moisture at a temperature not exceeding 25˚C. Do not freeze.
Keep the container tightly closed in order to protect from moisture.
Dosage: As directed by the Physician.